BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26177294)

  • 21. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
    Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
    Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.
    Tönges L; Günther R; Suhr M; Jansen J; Balck A; Saal KA; Barski E; Nientied T; Götz AA; Koch JC; Mueller BK; Weishaupt JH; Sereda MW; Hanisch UK; Bähr M; Lingor P
    Glia; 2014 Feb; 62(2):217-32. PubMed ID: 24311453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling.
    Taylor SJ; Dagger SA; Thien CB; Wikstrom ME; Langdon WY
    Blood; 2012 Nov; 120(19):4049-57. PubMed ID: 22990016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Rho-kinase inhibition using fasudil in mice with oxygen-induced retinopathy.
    Brockmann C; Corkhill C; Jaroslawska E; Dege S; Brockmann T; Kociok N; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1699-1708. PubMed ID: 31152312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rho Kinase Inhibitor, Fasudil, Attenuates Contrast-induced Acute Kidney Injury.
    Wang Y; Zhang H; Yang Z; Miao D; Zhang D
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):278-287. PubMed ID: 28929640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
    Ogata S; Morishige K; Sawada K; Hashimoto K; Mabuchi S; Kawase C; Ooyagi C; Sakata M; Kimura T
    Int J Gynecol Cancer; 2009 Dec; 19(9):1473-80. PubMed ID: 19955921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors.
    Greathouse KM; Henderson BW; Gentry EG; Herskowitz JH
    Behav Brain Res; 2019 Nov; 373():112083. PubMed ID: 31302146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
    He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG
    Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.
    Lee HS; Kim KS; Lim HS; Choi M; Kim HK; Ahn HY; Shin JC; Joe YA
    J Cell Biochem; 2015 Feb; 116(2):310-9. PubMed ID: 25185536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
    Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
    J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
    Ding RY; Zhao DM; Zhang ZD; Guo RX; Ma XC
    J Surg Res; 2011 Dec; 171(2):e209-14. PubMed ID: 21962807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasudil inhibits prostate cancer-induced angiogenesis in vitro.
    Chen W; Mao K; Hua-Huy T; Bei Y; Liu Z; Dinh-Xuan AT
    Oncol Rep; 2014 Dec; 32(6):2795-802. PubMed ID: 25333508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
    Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
    Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
    Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor fasudil reveals cytoskeletal and pro-survival responses.
    Lau CL; Perreau VM; Chen MJ; Cate HS; Merlo D; Cheung NS; O'Shea RD; Beart PM
    J Cell Physiol; 2012 Mar; 227(3):1199-211. PubMed ID: 21604263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.